-
Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus SeminarD Preiss, JA Tobert, GK Hovingh et al. -
Long-term effects of intensive glucose lowering on cardiovascular outcomesACCORD Study Group, HC Gerstein, ME Miller et al.
-
Canagliflozin and Renal Outcomes in Type 2 Diabetes and NephropathyPerkovic V, Jardine MJ, CREDENCE Trial Investigators.
-
Simple Electrocardiographic Measures Improve Sudden Arrhythmic Death Prediction in Coronary DiseaseNA Chatterjee, JT Tikkanen, PREDETERMINE Investigators et al.
-
Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes MellitusD Capodanno, DJ Angiolillo et al.
-
Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based StudiesMK Georgakis, JA de Lemos, C Ayers et al.
-
Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art ReviewL Cho, M Davis, and for the ACC CVD Womens Committee Members.
-
Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute WorkshopP Greenland, ED Michos, N Redmond et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
